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The Science Communication Competition is now in its fifth year. As in previous years, it aims to find young talented science writers 
and give them the opportunity to have their work published in The Biochemist. In 2015, a new branch of the competition was 
launched to include video entries. Overall this year’s competition attracted 47 entries and these were reviewed by our external 
panel of expert judges. The first prize in the written category was awarded to Emma Yhnell from Cardiff University, whose article is 
presented here; the winner of the video category was Chris Morgan from the University of Birmingham.
Chris Morgan’s winning video can be viewed on the Society’s website: http://bit.ly/1kxt8eH
giant gene, which creates an abnormally big, abnormally 
functioning protein.
The giant gene creates a long strand of huntingtin 
protein which, like the chain of a necklace, becomes 
tangled and knotted within the cells of the brain. 
These knotted clumps of huntingtin protein are called 
aggregates. There is a great amount of dispute about the 
function of the huntingtin aggregates. Some researchers 
think that aggregates are toxic, whereas others think 
that the formation of aggregates may be a protective 
mechanism. However, it is known that the build-up of 
huntingtin aggregates in the brain interrupts the chemical 
messages that control the body and mind and ultimately 
cause brain cells to die. This means that people with 
Huntington’s disease experience a range of symptoms, 
which affect all areas of their lives. Symptoms often begin 
with relatively subtle, but troubling, behavioural changes 
such as depression, anxiety and sleeping problems. These 
symptoms typically worsen and become more physically 
disabling causing shaking, mobility problems and lack of 
ability to eat. By the end stages of Huntington’s disease, 
often 10–15 years after diagnosis, people become very 
disabled and need constant care.
James and his wife were given the opportunity to see 
a genetic counsellor to discuss the implications of his 
diagnosis. He was told that the disease generally begins 
to affect people in their thirties and forties. The disease is 
heritable, as a person with Huntington’s disease has one 
faulty copy of the huntingtin gene and one good copy. This 
means there is a 50% chance the children of a person with 
Huntington’s disease could inherit the condition; one of 
James’s birth parents may have had a faulty copy of the 
huntingtin gene and passed it on to him. James’s could 
have unknowingly passed the faulty huntingtin gene on to 
his children, and they can choose to be tested for it once 
they are 18 years old.
Although we know the genetic cause of Huntington’s 
disease, we have not yet been able to cure it. This is 
because the molecular and biochemical processes that 
cause the disease are yet to be fully understood, as the 
James and the Giant Gene
I’d like you to meet James, he is a pretty normal chap. He 
works hard all week and looks forward to spending his 
weekends with his wife and two children.
But recently James has been feeling a bit down. He has 
been getting really moody with his family, he is lacking 
in motivation at work and he has had a few stumbles and 
falls around the house. After a few months of nagging 
from his wife, James booked an appointment to discuss 
his health with his doctor. James was adopted as a child, 
so he didn’t know of any medical conditions that ran in 
his family. The doctor referred him to a neurologist to 
investigate his symptoms further.
After many weeks of tests and investigations, James 
was called in to see a neurologist for his results. He 
received some life-changing news that would affect him 
and his family for the rest of their lives. “I’m sorry to have 
to tell you that you carry the gene for a rare brain condition 
known as Huntington’s disease and you are exhibiting 
some of the early symptoms. We can give you some 
treatments to control your symptoms but unfortunately, 
they will worsen over time and there is currently no cure.”
James did not know what to say. Finally, he had a 
name for what was causing the troubles that he had been 
experiencing for the past few months. But he also had so 
many unanswered questions. What had caused his disease? 
Could he have passed the disease on to his children?
The gene that causes James’s disease was discovered 
over 20 years ago. Scientists know that DNA contains the 
letters C, A, G and T which are arranged to spell genes, 
and these genes form proteins which are essential for the 
body to function properly. Everyone, including you and 
I, has a huntingtin gene, which is required for normal 
growth, development and health. The huntingtin gene 
contains a region of CAG letter repeats. Most people have 
a huntingtin gene with a small number of CAG repeats, 
normally between 10 and 35. But, people like James, who 
have Huntington’s disease, typically have over 40 CAG 
repeats within their huntingtin gene. The genetic region 
with the CAG letters has been misspelt with too many 
CAG letters. It has expanded, creating a bigger gene, a 
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size of the long tangled protein created from the giant 
gene makes it hard to study. However, we do know 
that the protein which causes Huntington’s disease is 
produced from a spelling mistake in the huntingtin 
gene, and if we can get rid of the giant misspelled 
protein then we might be able to prevent Huntington’s 
disease. Current research is focusing on using molecular 
techniques which prevent the formation of the giant 
huntingtin protein, to potentially improve the symptoms 
experienced by patients with Huntington’s disease.
One potential treatment for Huntington’s disease is 
to use small interfering RNA (siRNA) molecules, which 
are synthetically created to prevent proteins forming. 
Genes contain letters which need to be copied to spell out 
and create proteins. A bit like Tipp-Ex®, siRNAs are used 
to cover the copy of the ‘wrongly’ spelt genes so that the 
letters that spell the gene cannot be used to form proteins. 
siRNAs have been designed to bind to the copy of the giant 
huntingtin gene and prevent the formation of the abnormal 
protein. If the giant misspelled huntingtin protein can’t be 
formed this could prevent the disease from occurring, and 
the symptoms experienced by patients with Huntington’s 
disease may be improved. More research and development 
is required before siRNAs can be used as a possible 
treatment option for Huntington’s disease, but it is one 
option being investigated by researchers.
As well as looking in to possible treatments, we also 
need to better understand why the huntingtin gene causes 
Huntington’s disease. It is hoped that ongoing research in 
to this will improve the lives of people such as James who 
are currently living with Huntington’s disease, and for the 
many thousands of people who may go on to develop this 
devastating neurological disease. ■
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Some resources and further information 
The Huntington’s Disease Association (http://hda.org.uk/)
HDBuzz (http://en.hdbuzz.net)
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